Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients

Journal of Hypertension

Volumn 25, Issue 7, 2007, Pages 1427-1431

  Václavík, Jan ^a,b,d   Stejskal, David ^a   Lačňák, Bořek ^a   Lazárová, Marie ^a   Jedelský, Libor ^a   Kadalová, Lenka ^a   Janošová, Marie ^a   Fryšák, Zdeněk ^b   Vlček, Petr ^c  

^a Sternberk Hospital   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d NONE   (Czech Republic)

Author keywords

Hypertension; Metanephrine; Metanephrines; Normetanephrine; Pheochromocytoma; Secondary hypertension

Indexed keywords

METADRENALIN;

ADRENAL INCIDENTALOMA; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; HISTOLOGY; HUMAN; HYPERTENSION; IMAGING; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

EID: 34250313144     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32813aeb5a     Document Type: Article

References (23)

1. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005; 366:665-675.
2. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002; 287:1427-1434.
3. Eisenhofer G, Lenders JW, Pacak K. Biochemical dignosis of pheochromocytoma. Front Horm Res 2004; 31:76-106.
4. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001; 134:315-329.
5. Dluhy RG. Pheochromocytoma - death of an axiom. N Engl J Med 2002; 346:1486-1488.
6. Brouwers FM, Lenders JW, Eisenhofer G, Pacak K. Pheochromocytoma as an endocrine emergency. Rev Endocr Metab Disord 2003; 4:121-128.
7. Sawka AM, Jaeschke R, Singh RJ, Young WF. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocr Metab 2003; 88:553-558.
8. Stejskal D, Zuber R, Lačňák B, Horalík D, Prošková J, Andelová K, et al. Our experiences with pheochromocytoma diagnosis. Endocr Regul 2003; 37:127.
9. Lenders JW, Eisenhofer G, Armando I, Keiser HR, Goldstein DS, Kopin IJ. Determination of plasma metanephrines by liquid chromatography with electrochemical detection. Clin Chem 1993; 39:97-103.
10. Roden M, Raffesberg WR, Bernroider E, Niederle B, Waldhäusl W, Gasic S. Quantification of unconjugated metanephrines in human plasma without interference by acetaminophen. Clin Chem 2001; 47:1061-1067.
11. Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986; 110:13-20.
12. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148:839-843.
13. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein S. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004; 25:309-340.
14. Sawka AM, Prebtani AP, Thabane L, Gafni A, Levine M, Young WF. A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma. BMC Endocr Disord 2004; 4:2.
15. Eisenhofer G, Keiser H, Friberg P, Mezey E, Huynh TT, Hiremagalur B, et al. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocr Metab 1998; 83:2175-2185.
16. Eisenhofer G, Huynh TT, Hiroi M, Pacak K. Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma. Rev Endocr Metab Disord 2001; 2:297-311.
17. Eisenhofer G, Walther M, Keiser HR, Lenders JW, Friberg P, Pacak K. Plasma metanephrines: a novel and cost-effective test for pheochromocytoma. Braz J Med Biol Res 2000; 33:1157-1169.
18. Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JWM, Keiser HR, Pacak K. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocr Metab 2003; 88:2656-2666.
19. Sawka AM, Gafni A, Thanabe L, Young WF. The economic implications of three biochemical screening algorithms for pheochromocytoma. J Clin Endocr Metab 2004; 89:2859-2866.
20. Sawka AM, Thabane L, Gafni A, Levine M, Youg WF. Measurment of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age? BMC Endocr Disord 2005; 5:1.
21. Eisenhofer G. Biochemical diagnosis of pheochromocytoma - is it time to switch to plasma free metanephrines? [editorial]. J Clin Endocr Metab 2003; 88:550-552.
22. Ilias I, Pacak K. Diagnosis and management of tumors of the adrenal medulla. Horm Metab Res 2005; 37:717-721.
23. Brain KL, Kay J, Shine B. Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population. Clin Chem 2006; 52:2060-2064.